Tofacitinib (Xeljanz)
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Tofacitinib (Xeljanz), covering 2024-10-28 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea [NA]